Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dipraglurant (5 trials)
adx10059 (3 trials)
18f fpeb (1 trial)
Dyskinesias (Phase 2)
Esophagitis, Peptic (Phase 2)
Gastroesophageal Reflux (Phase 2)
Migraine Disorders (Phase 2)
Parkinson Disease (Phase 2)
Trials (8 total)
Trial APIs (3 total)